Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies

The prognosis of patients with non–small-cell lung cancer (NSCLC), traditionally determined by anatomic histology and TNM staging, neglects the biological features of the tumor that may be important in determining patient outcome and guiding therapeutic interventions. Identifying patients with NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazar, Vladimir, Girard, Nicolas, Raymond, Eric, Martini, Jean-François, Galbraith, Susan, Raynaud, Jacques, Bresson, Catherine, Solomon, Benjamin, Magidi, Shai, Nechushtan, Hovav, Onn, Amir, Berger, Raanan, Chen, Haiquan, Al-Omari, Amal, Ikeda, Sadakatsu, Lassen, Ulrik, Sekacheva, Marina, Felip, Enriqueta, Tabernero, Josep, Batist, Gerald, Spatz, Alan, Pramesh, C.S., Girard, Philippe, Blay, Jean-Yves, Philip, Thierry, Berindan-Neagoe, Ioana, Porgador, Angel, Rubin, Eitan, Kurzrock, Razelle, Schilsky, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489166/
https://www.ncbi.nlm.nih.gov/pubmed/36108261
http://dx.doi.org/10.1200/PO.22.00072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489166/
https://www.ncbi.nlm.nih.gov/pubmed/36108261
http://dx.doi.org/10.1200/PO.22.00072

Ejemplares similares